| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |